| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6014021 | Epilepsy & Behavior | 2011 | 6 Pages |
Abstract
⺠A retrospective pre-post analysis was conducted using multistate Medicaid data. ⺠Long-term clinical and cost benefits of vagus nerve stimulation therapy in drug-resistant epilepsy were evaluated. ⺠Health care resource use and epilepsy-related clinical events decreased post-implantation. ⺠Vagus nerve stimulation therapy was associated with net cost savings starting about 1.5 years post-implantation.
Keywords
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Sandra L. Helmers, Mei Sheng Duh, Annie Guérin, Sujata P. Sarda, Thomas M. Samuelson, Mark T. Bunker, Bryan D. Olin, Stanley D. Jackson, Edward Faught,